The second step in the biomarker research workflow is the development of specific assays for the analysis of the successfully identified biomarkers. The specifications of the assay characteristics, as the type of biomarker, the matrix and the technique(s) used for detection, have to be carefully selected to fit with its intended use, in accordance with the customer and regulatory requirements.
The BiomarkerBay partners have broad experience in assay development and offer high quality expertise and high flexibility in working with a large variety of samples and technologies, in research, patient care or CRO settings. Our list includes:
For an overview of established assays, please check our assay database.